Phage therapy for recurrent UTIs in kidney transplant patients
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older who has had a kidney transplant.
- You have had at least 2 UTIs in the last 6 months or 3 in the last year, all caused by E. coli bacteria.
- You can take the study medicine yourself or have a family member help you.
- If you can become pregnant, you must use effective birth control starting 1 month before the study and for 6 months after treatment ends.
- You are willing to follow all study procedures and be available for the entire study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical data from people with urinary tract infections (UTIs) to help future research and improve how UTIs are treated. You may be eligible if you have symptoms of a UTI now or have had them in the past.
This study tests whether specially targeted viruses (phages) can treat urinary tract infections caused by bacteria that don't respond to standard antibiotics. If you have a stubborn UTI that hasn't gotten better with antibiotics, this approach may offer a new option.
This trial tests whether continuing or stopping a specific antibiotic (TMP-SMX) after the first 6 months can prevent urinary tract infections (UTIs) in kidney transplant recipients who are at high risk for them.
This trial tests whether a special virus (bacteriophage) that attacks E. coli bacteria can help control bacteria in the bladder without causing an infection. It's for people with spinal cord injury who use a catheter and have E. coli in their urine but no active infection.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
This study looks at bacteria in urine samples from people who get frequent urinary tract infections and have a certain type of catheter. It aims to learn why some bacteria are hard to treat and may help improve care for patients like you.
Hear when a new Urinary Tract Infection, Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.